• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物治疗和减少伤害的选择,以治疗烟草依赖。

Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.

机构信息

Consultant in Public Health, Tobacco dependence, Amzer Glas , 176 rue de Brest, 35000 Rennes , France +332 99 33 72 67 ;

出版信息

Expert Opin Pharmacother. 2013 Oct;14(14):1959-67. doi: 10.1517/14656566.2013.818978. Epub 2013 Aug 26.

DOI:10.1517/14656566.2013.818978
PMID:23978314
Abstract

INTRODUCTION

Tobacco dependence, a chronic relapsing condition, requires repeated interventions and multiple attempts to quit.

AREAS COVERED

Strategies for assisting smoking cessation include behavioural counselling and pharmacotherapy. Three drugs are currently used as first-line pharmacotherapy: nicotine replacement therapy (NRT), bupropion and varenicline. Compared to placebo, the drug effect varies from RR = 2.27 for varenicline, to 1.69 for bupropion, and 1.60 for any form of NRT. Cytisine (similar to varenicline) has a RR = 3.98 compared to placebo (two trials). Second-line pharmacotherapies include nortriptyline and clonidine. This review also offers an overview of pipeline developments.

EXPERT OPINION

Effective medications exist, and clinicians should encourage and offer treatment to every smoker. However, most smokers try to quit by themselves, with only about 3% quitting successfully each year. Alternative interventions are needed. Harm reduction has not received much support to date. Safer alternative to tobacco smoking (smoke-free products, long-term use of cessation drugs, or electronic cigarettes) could save lives and reduce the burden of tobacco-related deaths and diseases. Despite some encouragement to develop a research agenda for e-cigarettes, particularly on the safety issues, too little attention has been brought to this area of research.

摘要

简介

烟草依赖是一种慢性复发性疾病,需要反复干预和多次尝试戒烟。

涵盖领域

帮助戒烟的策略包括行为咨询和药物治疗。目前有三种药物被用作一线药物治疗:尼古丁替代疗法(NRT)、安非他酮和伐尼克兰。与安慰剂相比,药物的效果从 RR = 2.27(用于伐尼克兰)到 RR = 1.69(用于安非他酮),再到 RR = 1.60(用于任何形式的 NRT)不等。烟碱类似物(与伐尼克兰相似)与安慰剂相比,RR = 3.98(两项试验)。二线药物治疗包括去甲替林和可乐定。本综述还概述了药物研发管道的进展。

专家意见

有效的药物确实存在,临床医生应该鼓励并为每个吸烟者提供治疗。然而,大多数吸烟者都试图自行戒烟,每年只有约 3%的人成功戒烟。需要替代干预措施。到目前为止,减少危害并没有得到太多支持。替代烟草吸烟的更安全方法(无烟雾产品、长期使用戒烟药物或电子烟)可以挽救生命,并减少与烟草相关的死亡和疾病的负担。尽管人们鼓励制定电子烟的研究议程,特别是关于安全问题,但对这一研究领域的关注仍然不足。

相似文献

1
Pharmacotherapies and harm-reduction options for the treatment of tobacco dependence.药物治疗和减少伤害的选择,以治疗烟草依赖。
Expert Opin Pharmacother. 2013 Oct;14(14):1959-67. doi: 10.1517/14656566.2013.818978. Epub 2013 Aug 26.
2
Emerging drugs for the treatment of tobacco dependence: 2014 update.治疗烟草依赖的新型药物:2014年更新版
Expert Opin Emerg Drugs. 2014 Jun;19(2):243-60. doi: 10.1517/14728214.2014.899580. Epub 2014 Mar 22.
3
Non-nicotinic therapies for smoking cessation.用于戒烟的非尼古丁疗法。
Annu Rev Pharmacol Toxicol. 2007;47:541-64. doi: 10.1146/annurev.pharmtox.47.120505.105354.
4
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.使用伐尼克兰(一种选择性α4β2烟碱受体部分激动剂)戒烟:一项为期7周、随机、安慰剂和安非他酮对照试验以及1年随访的结果
Arch Intern Med. 2006;166(15):1561-8. doi: 10.1001/archinte.166.15.1561.
5
Pharmacotherapy for smoking cessation: present and future.戒烟的药物治疗:现状与未来。
Curr Pharm Des. 2011;17(14):1343-50. doi: 10.2174/138161211796150837.
6
Adverse effects and tolerability of medications for the treatment of tobacco use and dependence.治疗烟草使用和依赖的药物的不良反应和耐受性。
Drugs. 2010 Dec 24;70(18):2357-72. doi: 10.2165/11538190-000000000-00000.
7
Nicotine dependence and smoking cessation.尼古丁依赖与戒烟
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2009 Nov;34(11):1049-57.
8
Treating tobacco dependence in women.治疗女性烟草依赖。
J Womens Health (Larchmt). 2007 Oct;16(8):1211-8. doi: 10.1089/jwh.2006.0281.
9
The neurobiological basis for partial agonist treatment of nicotine dependence: varenicline.尼古丁依赖部分激动剂治疗的神经生物学基础:伐尼克兰
Int J Clin Pract. 2006 May;60(5):571-6. doi: 10.1111/j.1368-5031.2006.00955.x.
10
Varenicline in the management of smoking cessation: a single technology appraisal.伐尼克兰在戒烟管理中的应用:一项单技术评估。
Health Technol Assess. 2009 Sep;13 Suppl 2:9-13. doi: 10.3310/hta13suppl2/02.

引用本文的文献

1
Attenuated nicotine-like effects of varenicline but not other nicotinic ACh receptor agonists in monkeys receiving nicotine daily.在每日接受尼古丁的猴子中,伐尼克兰具有减弱的尼古丁样效应,但其他烟碱型乙酰胆碱受体激动剂则没有。
Br J Pharmacol. 2016 Dec;173(24):3454-3466. doi: 10.1111/bph.13635. Epub 2016 Nov 6.
2
Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers.丹麦消费者中长期使用尼古丁替代疗法者的探索性调查研究。
Harm Reduct J. 2015 Jan 19;12:2. doi: 10.1186/1477-7517-12-2.
3
Extracts from presumed "reduced harm" cigarettes induce equivalent or greater toxicity in antigen-presenting cells.
来自所谓“降低危害”香烟的提取物在抗原呈递细胞中诱导出同等或更大的毒性。
Toxicology. 2015 Sep 1;335:46-54. doi: 10.1016/j.tox.2015.06.012. Epub 2015 Jul 10.
4
Identifying Medication Targets for Psychostimulant Addiction: Unraveling the Dopamine D3 Receptor Hypothesis.确定精神兴奋剂成瘾的药物靶点:揭开多巴胺 D3 受体假说。
J Med Chem. 2015 Jul 23;58(14):5361-80. doi: 10.1021/jm501512b. Epub 2015 Mar 31.
5
Optimizing treatments for nicotine dependence by increasing cognitive performance during withdrawal.通过提高戒断期间的认知表现来优化尼古丁依赖的治疗。
Expert Opin Drug Discov. 2014 Jun;9(6):579-94. doi: 10.1517/17460441.2014.908180. Epub 2014 Apr 7.